We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$63.8B
AUM Growth
+$3.93B
(+6.6%)
Cap. Flow
-$1.01B
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
22.75%
Holding
3,125
New
60
Increased
388
Reduced
2,521
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$20M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$11.8M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$11.8M |
| 4 |
Caesars Entertainment
CZR
|
+$11.1M |
| 5 |
PROG Holdings
PRG
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$59.2M |
| 2 |
PPLI
People Inc
PPLI
|
+$24.6M |
| 3 |
CZR
Caesars Entertainment Corporation
CZR
|
+$19.1M |
| 4 |
Teradyne
TER
|
+$16.1M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$15.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.2% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 12.55% |
| 4 | Consumer Discretionary | 11.87% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Costamare
CMRE
$1.77B
| $455K | ﹤0.01% |
75,028
-11,483
| -13% | -$58.8K |
|
2327
Syndax Pharmaceuticals
SNDX
$1.82B
| $454K | ﹤0.01% |
30,726
-3,018
| -9% | -$46K |
|
2328
KRONOS Worldwide
KRO
$989M
| $453K | ﹤0.01% |
35,190
-4,997
| -12% | -$59.9K |
|
2329
iShares S&P 100 ETF
OEF
$20.5B
| $453K | ﹤0.01% |
+2,907
| New | +$447K |
|
2330
VirnetX Holding Corp
VHC
$63.1M
| $452K | ﹤0.01% |
4,293
-591
| -12% | -$63.2K |
|
|
CLCT
2331
DELISTED
Collectors Universe
CLCT
| $452K | ﹤0.01% |
9,141
-1,069
| -10% | -$45.9K |
|
|
BCOV
2332
DELISTED
Brightcove, Inc.
BCOV
| $450K | ﹤0.01% |
43,966
-6,235
| -12% | -$62.2K |
|
|
STEL
2333
DELISTED
Stellar Bancorp
STEL
| $449K | ﹤0.01% |
27,499
-3,784
| -12% | -$63.3K |
|
2334
Hooker Furnishings Corp
HOFT
$166M
| $448K | ﹤0.01% |
17,345
-2,643
| -13% | -$62K |
|
2335
Ardelyx
ARDX
$997M
| $447K | ﹤0.01% |
85,085
-13,365
| -14% | -$80.3K |
|
2336
Replimune Group
REPL
$1.01B
| $446K | ﹤0.01% |
19,364
-1,068
| -5% | -$24.3K |
|
2337
A10 Networks
ATEN
$1.95B
| $445K | ﹤0.01% |
69,930
-10,700
| -13% | -$82K |
|
2338
Metallus
MTUS
$898M
| $445K | ﹤0.01% |
125,233
-13,835
| -10% | -$53.1K |
|
|
BCLI
2339
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $444K | ﹤0.01% |
1,751
-176
| -9% | -$36K |
|
2340
Akebia Therapeutics
AKBA
$252M
| $442K | ﹤0.01% |
176,016
-33,183
| -16% | -$291K |
|
2341
Daktronics
DAKT
$1.04B
| $441K | ﹤0.01% |
111,270
-8,732
| -7% | -$36.4K |
|
|
KLRS
2342
Kalaris Therapeutics
KLRS
$96.8M
| $441K | ﹤0.01% |
+698
| New | +$477K |
|
|
KE
2343
Kimball Electronics
KE
$628M
| $440K | ﹤0.01% |
38,076
-5,126
| -12% | -$67.2K |
|
2344
Crinetics Pharmaceuticals
CRNX
$8.92B
| $439K | ﹤0.01% |
27,987
-4,670
| -14% | -$71.4K |
|
|
THR
2345
DELISTED
Thermon Group Holdings
THR
| $439K | ﹤0.01% |
39,052
-6,866
| -15% | -$90.9K |
|
|
CODX
2346
Co-Diagnostics
CODX
$5.6M
| $437K | ﹤0.01% |
1,073
-167
| -13% | -$85.8K |
|
|
AMK
2347
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $437K | ﹤0.01% |
20,083
-2,926
| -13% | -$73.7K |
|
|
NGM
2348
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $437K | ﹤0.01% |
27,475
-4,116
| -13% | -$75.1K |
|
|
STFC
2349
DELISTED
State Auto Financial Corp
STFC
| $437K | ﹤0.01% |
31,763
-3,741
| -11% | -$59.7K |
|
2350
RPC Inc
RES
$1.3B
| $434K | ﹤0.01% |
164,343
-7,415
| -4% | -$23.1K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2020 Portfolio in Review
As of Q3 2020, RhumbLine Advisers held 3,125 positions worth $63.8B, up 6.6% from $59.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
RhumbLine Advisers's Q3 2020 filing shows 60 new, 388 increased, 2,521 reduced and 139 closed positions. Its largest new stake was PROG Holdings: 245,531 shares worth $11.8M. The largest sale was Apple, an estimated $59.2M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2020 buy was PROG Holdings: 245,531 shares worth $11.8M.
- RhumbLine Advisers added most to Match Group in Q3 2020, an estimated $20M increase.
- RhumbLine Advisers's biggest Q3 2020 reduction was Apple, cutting an estimated $59.2M.
- RhumbLine Advisers fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $19.1M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $63.8B portfolio in Q3 2020.
- RhumbLine Advisers opened 60 new positions and closed 139 in Q3 2020.
- RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $63.8B.
Based on RhumbLine Advisers's 13F filing for Q3 2020, filed 12 Nov 2020.